TOPK-p38/JNK-IN-1 is an orally active TOPK-p38/JNK inhibitor with anti-inflammatory activity; it inhibits nitric oxide (NO) production (IC50 = 2.14 µM) and suppresses phosphorylation of downstream related proteins, thereby preventing TOPK degradation.